Cleared Abbreviated

K071573 - RUGALIFT, MODEL# V.2.1

K071573 is an FDA 510(k) clearance for RUGALIFT, manufactured by Fatrotek S.R.L.. The device is a Class 2 Neurology device with product code NFO cleared through the Abbreviated 510(k) pathway after a 550-day FDA review.

K071573 · Fatrotek S.R.L. · Neurology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Dec 2008
Decision
550d
Days
Class 2
Risk

K071573 is an FDA 510(k) clearance for the RUGALIFT, MODEL# V.2.1. Classified as Stimulator, Transcutaneous Electrical, Aesthetic Purposes (product code NFO), Class II - Special Controls.

Submitted by Fatrotek S.R.L. (Auvernier, CH). The FDA issued a Cleared decision on December 9, 2008 after a review of 550 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: High-complexity regulatory submission. Standards-verified equivalence. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

FDA 510(k) Submission Details - K071573

510(k) Number K071573 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 08, 2007
Decision Date December 09, 2008
Days to Decision 550 days
Submission Type Abbreviated
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
401d slower than avg
Panel avg: 149d · This submission: 550d
Pathway characteristics
Standards-based clearance path.

NFO Device Classification - Class 2, Special Controls

Product Code NFO Stimulator, Transcutaneous Electrical, Aesthetic Purposes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - NFO Stimulator, Transcutaneous Electrical, Aesthetic Purposes

All 80
Devices cleared under the same product code (NFO) and FDA review panel - the closest regulatory comparables to K071573.
THE BUZZ FACIAL TONING SYSTEM
K102494 · Daka International , Ltd. · Dec 2011
BMR FACE
K103031 · Bio-Medical Research, Ltd. · Nov 2011
NUFACE PLUS
K103472 · Carol Cole Company · Nov 2011
NUTRITONE FACIAL BEAUTY SYSTEM
K070250 · Isomers Laboratories, Inc. · Sep 2008
INTERX 1000/DERMA 200 STIMULATOR FOR COSMETIC USE
K070217 · Neuro Resource Group, Inc. · Apr 2008
NUFACE, MODEL NU-4003
K072260 · Carol Cole Company · Nov 2007
K071573 · RUGALIFT, MODEL# V.2.1
Download PDF FDA Summary Fatrotek S.R.L.